13G Filing: Barrett Ehrlich and Oncbiomune Pharmaceuticals, Inc (OBMP)

Page 6 of 6

Page 6 of 6 SEC Filing

CUSIP No. 68235A101   13G/A  

Page 6
of 6 Pages

 

Item 10.  Certification.

  (a)   The following certification shall be
included if the statement is filed pursuant to §240.13d-1(b):
 
      By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired
and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
  (b)   The following certification shall be
included if the statement is filed pursuant to §240.13d-1(c):
 
      By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.

After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.

MARCH 2, 2016

Date

THE BARRETT EDGE INC.

/s/
BARRETT EHRLICH

Signature

BARRETT
EHRLICH, PRESIDENT

Name/Title

BARRETT EHRLICH

/s/
BARRETT EHRLICH

Signature

BARRETT
EHRLICH

Name/Title

Follow Theralink Technologies Inc. (OTCMKTS:THER)

Page 6 of 6